Zielinski CC - Search Results

1

The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.

Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG; Austrian Fulvestrant Registry. Bartsch R, et al. Among authors: zielinski cc. Breast Cancer Res Treat. 2009 May;115(2):373-80. doi: 10.1007/s10549-008-0132-0. Epub 2008 Jul 26. Breast Cancer Res Treat. 2009. PMID: 18661231 Clinical Trial.

2

[Effect of various factors on survival after recurrent and/or metastatic breast cancer].

Sevelda P, Kührer I, Zielinski CC, Vavra N, Seifert M, Kubista E, Czerwenka K, Spona J, Salzer H. Sevelda P, et al. Among authors: zielinski cc. Geburtshilfe Frauenheilkd. 1991 May;51(5):387-92. doi: 10.1055/s-2007-1026164. Geburtshilfe Frauenheilkd. 1991. PMID: 1869009 Clinical Trial. German.

3

Impaired production of tumor necrosis factor in breast cancer.

Zielinski CC, Mueller C, Tyl E, Tichatschek E, Kubista E, Spona J. Zielinski CC, et al. Cancer. 1990 Nov 1;66(9):1944-8. doi: 10.1002/1097-0142(19901101)66:9<1944::aid-cncr2820660916>3.0.co;2-w. Cancer. 1990. PMID: 2224791

4

Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Tichatschek E, Zielinski CC, Müller C, Sevelda P, Kubista E, Czerwenka K, Spona J, Wolf H, Eibl MM. Tichatschek E, et al. Among authors: zielinski cc. Cancer Immunol Immunother. 1988;27(3):278-82. doi: 10.1007/BF00205452. Cancer Immunol Immunother. 1988. PMID: 2460239 Free PMC article.

5

Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer.

Zielinski CC, Tichatschek E, Müller C, Kalinowski W, Sevelda P, Czerwenka K, Kubista E, Spona J. Zielinski CC, et al. Cancer. 1989 May 15;63(10):1985-9. doi: 10.1002/1097-0142(19890515)63:10<1985::aid-cncr2820631019>3.0.co;2-b. Cancer. 1989. PMID: 2702570

6

Serum osteocalcin levels in breast cancer patients.

Pietschmann P, Zielinski C, Woloszczuk W. Pietschmann P, et al. J Cancer Res Clin Oncol. 1989;115(5):456-8. doi: 10.1007/BF00393337. J Cancer Res Clin Oncol. 1989. PMID: 2808485

7

Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer.

Zielinski CC, Stuller I, Rausch P, Müller C. Zielinski CC, et al. J Cancer Res Clin Oncol. 1988;114(5):514-8. doi: 10.1007/BF00391503. J Cancer Res Clin Oncol. 1988. PMID: 3182912

8

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Wiltschke C, Krainer M, Budinsky AC, Berger A, Müller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. Br J Cancer. 1995 Jun;71(6):1292-6. doi: 10.1038/bjc.1995.250. Br J Cancer. 1995. PMID: 7779726 Free PMC article.

9

Impaired hemorheology in patients with postmastectomy lymphedema.

Djavanmard MP, Michl I, Korpan M, Fazeny B, Budinsky AC, Wiesinger E, Weinländer G, Binder M, Püspök M, Zielinski CC, Fialka V, Koppensteiner R, Marosi C. Djavanmard MP, et al. Among authors: zielinski cc. Breast Cancer Res Treat. 1996;38(3):283-8. doi: 10.1007/BF01806147. Breast Cancer Res Treat. 1996. PMID: 8739081

10

Tissue expression and serum levels of HER-2/neu in patients with breast cancer.

Krainer M, Brodowicz T, Zeillinger R, Wiltschke C, Scholten C, Seifert M, Kubista E, Zielinski CC. Krainer M, et al. Among authors: zielinski cc. Oncology. 1997 Nov-Dec;54(6):475-81. doi: 10.1159/000227606. Oncology. 1997. PMID: 9394844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

493 results

Search Page